Related Experiment Video
Updated: Sep 12, 2025
11:54
Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
25.8K
KCNC1-Related Progressive Myoclonus Epilepsy: A Case Report
Mehri Salari1, Sara Sadeghzadeh2, Masoud Etemadifar3
1Shahid Beheshti University of Medical Sciences Tehran Iran.
Clinical Case Reports
|August 6, 2025
Summary
KCNC1-related progressive myoclonus epilepsy (EPM7) is a rare genetic disorder. Genetic testing is crucial for diagnosing this epilepsy syndrome and exploring future treatments like gene therapy.
Area of Science:
- Genetics
- Neurology
- Rare Diseases
Background:
- Progressive myoclonus epilepsy (EPM7) is a rare neurological disorder.
- It is characterized by seizures, myoclonus, and ataxia.
- The genetic basis involves mutations in the KCNC1 gene.
Purpose of the Study:
- To report the first case of KCNC1-related EPM7 in Iran.
- To emphasize the importance of genetic testing for diagnosis.
- To discuss potential therapeutic strategies.
Main Methods:
- Clinical case presentation.
- Genetic analysis (details not provided in abstract).
Main Results:
- The first documented Iranian patient with KCNC1-related EPM7 was identified.
- This case underscores the diagnostic utility of genetic testing.
Conclusions:
- Genetic testing is essential for diagnosing KCNC1-related EPM7.
- Future research may focus on gene therapy and novel pharmacological treatments for this epilepsy syndrome.
Related Concept Videos
01:13Seizures: Classification
593
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
593
01:24Epilepsy and Seizures: Overview
280
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280
01:20Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
01:14Antiepileptic Drugs: Glutamate Antagonists
516
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
516
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
650
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
650